Updated Jul 16, 2026
Tezel Ahmet has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Ahmet Tezel is a corporate executive currently serving as the Chief Innovation Officer at LivaNova PLC, a global medical technology company focused on developing and commercializing innovative therapies for the treatment of cardiovascular and neuromodulation conditions.
| Role | Chief Innovation Officer |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-17 | LIVN | LivaNova PLC | F — Tax withholding / forfeiture | 1.0K | $79.70 | $82K |
| 2026-06-17 | LIVN | LivaNova PLC | M — Option exercise | 3.0K | $0.00 | |
| 2026-04-01 | LIVN | LivaNova PLC | F — Tax withholding / forfeiture | 1.2K | $61.27 | $73K |
| 2026-04-01 | LIVN | LivaNova PLC | M — Option exercise | 3.4K | $0.00 |
Ahmet Tezel is a corporate executive currently serving as the Chief Innovation Officer at LivaNova PLC, a global medical technology company focused on developing and commercializing innovative therapies for the treatment of cardiovascular and neuromodulation conditions.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Tezel Ahmet profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.